To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC65901 | PSB-1901 Featured |
PSB-1901 is a potent A2B adenosine receptor (A2BAR) antagonist with Kis of 0.0835 nM and 0.131 nM for human and mouse A2BARs respectively. PSB-1901 can be used for the research of cancer.
More description
|
|
| DC65899 | Des-iPr-TAS-116 Featured |
|
|
| DC11286 | WJ460 Featured |
WJ460 is one of the lead compounds exerting anti-metastatic activity in the nanomolar range in breast cancer cells.
More description
|
|
| DC72750 | GNE-9822 Featured |
GNE-9822 is a potent, orally active and selective ITK inhibitor with a Ki value of 0.7 nM. GNE-9822 has good ADME properties. GNE-9822 can be used in research of asthma.
More description
|
|
| DC65898 | LMTK3 inibitor C28 Featured |
LMTK3-IN-1 (compound C28) is an ATP-competitive inhibitor of lemur tyrosine kinase 3 (LMTK3) (Kd=2.5 μM),that acts by degrading LMTK3 via the ubiquitin-proteasome pathway. LMTK3-IN-1 shows anticancer activity in a variety of cancer cell lines and in vivo BC mouse models. LMTK3-IN-1 induces apoptosis in BC cell lines at 10-20 μM.
More description
|
|
| DC65897 | SLU-PP-1072 Featured |
SLU-PP-1072 is a novel Selective ERRα/γ Inverse Agonist, Inhibiting the Warburg Effect and Inducing Apoptosis in Prostate Cancer Cells.
More description
|
|
| DC70798 | SRX3177 Featured |
SRX3177 is a potent, triple BRD4/PI3K/CDK4/6 inhibitor with nanomolar potency against PI3Kα (IC50=79 nM), BRD4 bromodomains (BD1 and BD2) (IC50=33 nM and 89 nM, respectively), and CDK4/6 (IC50=2.5/3.3 nM).SRX3177 is capable of targeting BRD4, PI3K and CDK4/6 simultaneously, induces apoptosis and cell cycle arrest and has in vitro efficacy in mantle cell lymphoma, hepatocellular carcinoma and neuroblastoma models.SRX3177 has antitumor efficacy in in vivo xenograft models and is less toxic than the combination of agents that inhibit individual targets.
More description
|
|
| DC65896 | PSB-15160 Featured |
|
|
| DC65895 | 5-Acetyl-2-bromobenzaldehyde Featured |
|
|
| DC65894 | 3-bromo-2-(2-hydroxyethyl)thiophene Featured |
|
|
| DC65893 | Pyrithione Featured |
Pyrithione, a Transition metal complexe, is a zinc ionophore that causes increased zinc levels within mammalian cells. Pyrithione has potent bactericidal and anti-fungal activity.
More description
|
|
| DC65892 | Cyclopropyl-prop-2-ynyl-amine Featured |
|
|
| DC47388 | PROTAC SHP2 degrader-1 Featured |
PROTAC SHP2 degrader-1 is a potent and effective SHP2 degrader. PROTAC SHP2 degrader-1 induces SHP2 degradation requires binding to VHL-1 and SHP2 proteins and is also neddylation- and proteasome-dependent.
More description
|
|
| DC71874 | MIF098 Featured |
MIF098 is a macrophage migration inhibitory factor (MIF) antagonist. MIF098 inhibits proliferation, migration and fibrosis of pulmonary smooth muscle cells. MIF098 can be used for immunoinflammation-related disease research.
More description
|
|
| DC43804 | VAS3947 Featured |
Selective inhibitor of NADPH oxidase activity in low micromolar concentrations, interfering neither with ROS detection nor with XOD or eNOS activities
More description
|
|
| DC65891 | GI 181771 Featured |
GI 181771 is a cholecystokinin 1 receptor agonist investigated for the treatment of obesity.
More description
|
|
| DC44929 | Cyclotriazadisulfonamide Featured |
Cyclotriazadisulfonamide (CADA) is a specific CD4-targeted HIV entry inhibitors. Cyclotriazadisulfonamide (CADA) inhibits the co-translational translocation of human CD4 (huCD4) into the ER lumen in a signal peptide (SP)-dependent way.
More description
|
|
| DC65889 | 3-Oxa-1-azaspiro[4.5]decane-2,4-dione Featured |
|
|
| DC65888 | 2,4,6-Triisopropyl-m-phenylene diisocyanate Featured |
|
|
| DC65886 | MCU-i11 Featured |
MCU-i11 is a novel negative modulator of the MCU, binding MICU1 and impairing muscle cell growth.
More description
|
|
| DC21437 | OAT-2068 Featured |
OAT-2068 is a potent, selective, orally bioavailable inhibitor of mouse chitotriosidase (mCHIT1) with IC50 of 29 nM, 143-fold selectivity over mAMCase.
More description
|
|
| DC34054 | PHPS1 Featured |
PHPS1 is an inhibitor of the protein tyrosine phosphatase Shp2. PHPS1 also efficiently inhibits activation of Erk1/2 by the leukemia-associated Shp2 mutant, Shp2-E76K, and blocks the anchorage-independent growth of a variety of human tumor cell lines.
More description
|
|
| DC12414 | ZLc002 Featured |
ZLc002 (ZLc-002) is a putative small-molecule inhibitor of nNOS interaction with NOS1AP, disrupts neuronal nitric oxide synthase-NOS1AP interaction in intact cells.
More description
|
|
| DC65885 | Stilbamidine dihydrochloride Featured |
Stilbamidine dihydrochloride is a blocker of neuromuscular transmission and axonal conduction. It is used to study the distribution of the drug in the organs and tissues of rats following intravenous injection.
More description
|
|
| DC65884 | CCR2-RA Featured |
|
|
| DC42752 | HaloPROTAC3 Featured |
HaloPROTAC3 is a degrader of HaloTag fusion proteins.
More description
|
|
| DC65883 | 3,5-Dichloro-6-iodopyrazolo[1,5-a]pyrimidine Featured |
|
|
| DC65882 | Methyl 2-Formyl-1H-Pyrrole-3-Carboxylate Featured |
|
|
| DC65881 | Afabicin Featured |
Afabicin (formerly Debio 1450, AFN-1720) is a prodrug of afabicin desphosphono, an enoyl-acyl carrier protein reductase (FabI) inhibitor, and is a first-in-class antibiotic with a novel mode of action to specifically target fatty acid synthesis in Staphylococcus spp.
More description
|
|
| DC65880 | HaloPROTAC-E Featured |
HaloPROTAC-E is a novel HaloPROTAC potent degrader, inducing reversible degradation of two endosomally localized proteins, SGK3 and VPS34, with a DC50 of 3-10 nM, remarkably selective inducing only degradation of the Halo tagged endogenous VPS34 complex (VPS34, VPS15, Beclin1, and ATG14) and no other proteins were significantly degraded.
More description
|
|